EUVIMEDEUVIMED entdecken
Crossref

SOX4 inhibits ferroptosis and promotes proliferation of endometrial cancer cells via the p53/ SLC7A11 signaling

Hongli Zhu, Song Xu iD

Journal of Obstetrics and Gynaecology Research · 2024

DOI: 10.1111/jog.16094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Hongli Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Affliated Hangzhou First People's Hospital of Zhejiang University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Ferroptosis, SOXC Transcription Factors, Amino Acid Transport System y+, Endometrial Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Zhejiang Medicine and Health Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Sex‐determining region Y‐related high‐mobility group box 4 (SOX4) has been reported to play a carcinogenic role in endometrial cancer (EC). However, the biological function and regulatory mechanisms of SOX4 in ferroptosis during the progression of EC are still unknown.

Methods

The mRNA and protein levels were scrutinized by quantitative reverse‐transcription polymerase chain reaction and western blot, respectively. The cell viability and proliferative capability were determined by cell counting kit‐8 assay and 5‐ethynyl‐2′‐deoxyuridine (EdU) assay. Transcriptional regulation of gene expression was investigated by dual‐luciferase reporter assay and chromatin immunoprecipitation. Ferroptosis was evaluated by detection of reactive oxygen species, malondialdehyde, Fe 2+ , and ferroptosis‐related proteins. The mice test was implemented to confirm the influence of SOX4 on EC tumor growth and ferroptosis in vivo.

Results

We here discovered the elevation of SOX4 in EC tissues and cells. Functionally, SOX4 knockdown hampered proliferation and promoted ferroptosis of EC cells. Mechanistically, SOX4 bound to p53 promoter and inhibited its transcriptional activity in EC cells. In addition, p53 transcriptionally suppressed SLC7A11 expression in EC cells. Downregulation of p53 reverses the effect of SOX4 knockdown on proliferation and ferroptosis of EC cells. Finally, in vivo experiments demonstrated that SOX4 depletion hindered tumor growth and triggered ferroptosis in EC.

Conclusions

These findings collectively suggested that SOX4 inhibited ferroptosis and promoted proliferation of EC cells via the p53/SLC7A11 signaling. Our research unveiled a novel regulatory mechanism of ferroptosis in EC, offering promising perspectives for the development of EC therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisSOXC Transcription FactorsAmino Acid Transport System y+Endometrial NeoplasmsTumor Suppressor Protein p53Cell ProliferationFemaleHumansMiceAnimalsCell Line, TumorSignal TransductionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

SLC7A11SOX4endometrial cancerferroptosisp53

Substanzen

SOXC Transcription FactorsAmino Acid Transport System y+SLC7A11 protein, humanTumor Suppressor Protein p53SOX4 protein, humanTP53 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Affliated Hangzhou First People's Hospital of Zhejiang University, Hangzhou, Zhejiang, China.

ORCID-Profile: Song Xu

Förderung

  • Zhejiang Medicine and Health Science and Technology Project

Zitieren

APA

Zhu, H., & Xu, S. (2024). SOX4 inhibits ferroptosis and promotes proliferation of endometrial cancer cells via the p53/ SLC7A11 signaling. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16094

Vancouver

Zhu H, Xu S. SOX4 inhibits ferroptosis and promotes proliferation of endometrial cancer cells via the p53/ SLC7A11 signaling. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.16094

BibTeX
@article{Zhu2024,
  author = {Zhu, Hongli and Xu, Song},
  title = {SOX4 inhibits ferroptosis and promotes proliferation of endometrial cancer cells via the p53/ SLC7A11 signaling},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2024},
  doi = {10.1111/jog.16094}
}
Kostenlos starten →